Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results Of The Company For The Quarter And Nine months Ended on 31.12.2025
Omkar Pharmachem Ltd. Press Release Feb 04 2026
Filed with BSE ·
6ix hasn’t read this filing yet.
Earlier from Omkar Pharmachem
- Omkar Pharmachem Ltd. Press Release Jan 27 2026
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.
- Omkar Pharmachem Ltd. Press Release Jan 10 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Omkar Pharmachem Ltd. Press Release Jan 07 2026
Later from Omkar Pharmachem
- Omkar Pharmachem Ltd. Press Release Feb 12 2026
- Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests From 01St January, 2026 To 06Th January 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015
- Omkar Pharmachem Ltd. Press Release Feb 16 2026
Follow Omkar Pharmachem into a list and get an email when it puts out news.
Follow Omkar Pharmachem